RSM has submitted a comment letter to U.S. Congressional leaders addressing the recent requirement to capitalize and amortize research and experimental expenditures, as defined under section 174 of the Internal Revenue Code, in accordance with the Tax Cuts and Jobs Act (TCJA) as enacted in 2017.
RSM supports swift action to repeal this new capitalization provision and reinstate the ability to immediately expense qualifying research costs under section 174.
